1.
Khan A, Fatima U, Zaidi U, Munir A, Aslam H. Pharmacogenomic Insights Into The Response To Imatinib In Chronic Myeloid Leukaemia: The Role Of CYP3A4 Polymorphisms. JRMC [Internet]. 2025 Dec. 31 [cited 2026 Jan. 20];29(4). Available from: https://mail.journalrmc.com/index.php/JRMC/article/view/2975